Abstract:Background: The metabolism study of active components for traditional Chinese medicine (TCM) in target organs is conducive to clarify the authentic active ingredients. Notoginsenoside R1 (NG-R1), one of the bioactive components of Panax notoginsenoside (PNS), is commonly acknowledged as the characteristic marker of PNS. However, the metabolism of NG-R1 in target organs has not been clarified yet due to the lack of robust technique and approach. Purpose: The present study aimed to develop a reliable and efficient strategy and technology for revealing the qualitative and quantitative metabolism of active components of TCMs in target organs, and to clarify the biotransformation of NG-R1 in liver-brain-intestinal axis. Methods: The metabolic transformation of NG-R1 in the brain gut axis was investigated in the in vitro incubation system of fresh rat brain, liver homogenate, and intestinal flora. To quickly lock the target metabolites, we set the mass defect filter (MDF) in different ranges to screen metabolites with different molecular weight (MW). This strategy was defined as multi-stage MDF (mMDF). In addition, we performed relative quantitative analysis on all metabolites according to the peak area acquired by LC-IT-TOF/MS to overcome the challenge that metabolites are difficult to be quantified due to the lack of standards. Results: When MDF was set at 0.50 to 0.65 to screen metabolites with MW of 900 to 1200 Da, 6 novel metabolites were quickly found, and then identified as glucuronic acid binding, oxidation, dehydrogenation, methylation and hydrogenation products according to their LC and MS characteristics. When setting MDF at 0.42 - 0.52, 6 metabolites with MW of 600 to 900 Da were effectively screened and identified as Rg1, NG-R2, Rh1, Rg1+CH2+2H and Rg1+CH2. To screen the metabolites with MW of 300 to 600 Da, MDF was set at 0.25 - 0.42, and 4 novel metabolites were screened rapidly. The results of quantitative metabolism suggested that intestinal flora was the main metabolic site of NG-R1 in rat, and more than 60% of NG-R1 was converted to Rg1 by deglycosylation in the intestinal flora. Conclusion: The mMDF strategy can significantly improve the research efficiency of qualitative metabolism of saponins. Although NG-R1 could be transformed into a variety of metabolites in rat liver and brain homogenate, it still existed mainly in prototype form. In the rat flora, NG-R1 mainly existed in the form of deglycosylated metabolite Rg1.

Identification and Quantitative Investigation of the Effects of Intestinal Microflora on the Metabolism and Pharmacokinetics of Notoginsenoside Fc Assayed by Liquid Chromatography with Electrospray Ionization Tandem Mass Spectrometry

Effect of Fermentation-Assisted Extraction on the Bioactivity of Panax Notoginseng Saponins

Quantification of Panax Notoginseng Saponins Metabolites in Rat Plasma with in Vivo Gut Microbiota-Mediated Biotransformation by HPLC-MS/MS

In Vivo Metabolic Profiles of Panax Notoginseng Saponins Mediated by Gut Microbiota in Rats

Identification of Constituents in Gui-Zhi-Jia-Ge-Gen-Tang by LC-IT-MS Combined with LC-Q-TOF-MS and Elucidation of Their Metabolic Networks in Rat Plasma after Oral Administration.

Qualitatively and quantitatively investigating the metabolism of 20(S)-protopanaxadiol-type ginsenosides by gut microbiota of different species

Metabolic Characteristics of Ginsenosides from Panax Ginseng in Rat Feces Mediated by Gut Microbiota.

Metabolic Analysis of Panax Notoginseng Saponins with Gut Microbiota-Mediated Biotransformation by HPLC-DAD-Q-TOF-MS/MS

In vivo pharmacokinetics of ginsenoside compound K mediated by gut microbiota

Comparative Characterization of the Ginsenosides from Six Panax Herbal Extracts and Their in Vitro Rat Gut Microbial Metabolites by Advanced Liquid Chromatography-Mass Spectrometry Approaches.

Combinatorial Metabolism Notably Affects Human Systemic Exposure to Ginsenosides from Orally Administered Extract of Panax Notoginseng Roots (Sanqi)

Characterization of Metabolism and in Vitro Permeability Study of Notoginsenoside R1 from Radix Notoginseng

Different absorption and metabolism of ginsenosides after the administration of total ginsenosides and decoction of<i>Panax ginseng</i>

Different absorption and metabolism of ginsenosides after the administration of total ginsenosides and decoction of <scp> <i>Panax ginseng</i> </scp>

Integrated metabolomic and transcriptomic analyses revealed the distribution of saponins in Panax notoginseng

Global analysis of qualitative and quantitative metabolism of Notoginsenoside R1 in rat liver-brain-gut axis based on LC-IT-TOF/MS combing mMDF strategy

Application of Ultra-Performance LC-TOF MS Metabolite Profiling Techniques to the Analysis of Medicinal Panax Herbs

Personalized Bioconversion of Panax Notoginseng Saponins Mediated by Gut Microbiota Between Chinese-diet and Western-diet Healthy Subjects

Effects of Intestinal Microecology on Metabolism and Pharmacokinetics of Oral Wogonoside and Baicalin

Metabolomes and transcriptomes revealed the saponin distribution in root tissues of Panax quinquefolius and Panax notoginseng

Comprehensive fecal metabolomics and gut microbiota for the evaluation of the mechanism of Panax Ginseng in the treatment of Qi-deficiency liver cancer